KPD Consolidation After ASCT in NDMM Patients

Clinical trial NCT06879379 · RECRUITING

Trial details

NCT number: NCT06879379
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma, Newly Diagnosed

Start date: 2025-03-01
Primary completion: 2028-03-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.